等待开盘 02-02 09:30:00 美东时间
-0.720
-2.16%
Issued on behalf of Oncolytics Biotech Inc. Equity-Insider.com News Commentary VANCOUVER, BC, Jan. 30, 2026 /PRNewswire/ -- The oncology sector is undergoing a massive capital rotation driv...
01-30 23:36
今日重点评级关注:Piper Sandler:维持Praxis Precision Medicine"超配"评级,目标价从450美元升至1200美元;Tigress Financial:维持Main International ETF"买入"评级,目标价从52美元升至66美元
01-29 11:06
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab (NASDAQ:GMAB) with a Buy and maintains $39 price target.
01-28 21:43
Nextpower Inc. Class A涨12.55%;F5网络涨10.44%;希捷科技涨10.02%
01-28 17:22
BioNTech SE announced on January 28, 2026, the appointment of Kylie Jimenez as Chief People Officer (CPO) effective March 1, 2026. This move aligns with the company’s goal to become a multi-product oncology company by 2030 and reflects the importance of its global workforce. Jimenez, a seasoned HR executive with over 20 years of experience, joins from Georg Fischer where she served as global CHRO. She brings expertise in developing sustainable pe...
01-28 13:00
FOCUS-Drugmakers turn to AI to speed trials, regulatory submissions Pharmaceutical companies describe AI benefits for tedious work Novartis says AI cut trial site selection from weeks to a two-hour meeting Drugmakers use AI to draft regulator-ready filings By Maggie Fick and Michael Erman SAN FRANCI
01-26 19:00
今日重点评级关注:HC Wainwright & Co.:维持Soleno Therapeutics"买入"评级,目标价从110美元升至120美元;富国银行:维持Soleno Therapeutics"超配"评级,目标价从106美元升至114美元
01-21 11:42
Based on the topline results from the EPCORE® DLBCL-1 trial, Genmab will engage global regulatory authorities to discuss next steps COPENHAGEN, Denmark; January 16, 2026 – Genmab A/S (NASDAQ:GMAB) today
01-17 02:33
泰纳瑞斯钢铁涨3.81%;RELX PLC Sponsored ADR涨3.34%;DraftKings, Inc. Class A涨1.75%
01-15 07:11
那些关于药品定价政策及可能侵蚀利润的关税措施的最坏担忧均未成真,行业焦虑情绪得到明显缓解。 智通财经APP获悉,下周,制药商们将赴旧金山出席摩根大通医疗健康年...
01-10 00:49